FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs.
|Recent Press Releases||More »|
|Upcoming Events||More »|
|Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources|